Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection
Clinical trial NCT03588923 · COMPLETED
Trial details
- NCT number
- NCT03588923
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-07
- Primary completion
- 2018-08-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.